NEW YORK, March 14, 2011 (GLOBE NEWSWIRE) — Harris & Harris Group, Inc. (Nasdaq:TINY) noted that Solazyme, Inc. filed a registration statement with the Securities and Exchange Commission on Friday, March 11, 2011, to sell shares of common stock in an initial public offering.
Harris & Harris Group is an investor in privately held Solazyme, Inc.
Harris & Harris Group is a publicly traded venture capital company that invests in nanotechnology and microsystems. Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com.
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company’s press release. Please see the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company’s business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company’s actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The reference to the website www.HHVC.com has been provided as a convenience, and the information contained on such website is not incorporated by reference into this press release.
CONTACT: DOUGLAS W. JAMISON TEL. NO. (212) 582-0900